Newmont: A Good Value In This Market (NYSE:NEM)


The stock market has rebounded significantly since the lows in March and many high quality companies have seen massive price gains in their stocks. In this environment, it makes finding reasonably priced stocks more difficult. For example, I own shares of PayPal (PYPL), which is a high quality company withRead More →

BioCryst NDA Accepted, And Other News: The Good, Bad And Ugly Of Biopharma – BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)


BioCryst Pharmaceuticals Goes Ahead with FDA Marketing Application BioCryst Pharmaceuticals (BCRX) reported that the FDA has accepted its marketing application for review. The application pertains to its drug candidate Berotralstat designed to prevent hereditary angioedema attacks. The PDUFA date for the drug has been set at December 3, 2020. AccordingRead More →

Tonix Pharmaceuticals Moves Ahead, And Other News: The Good, Bad, And Ugly Of Biopharma – Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)


Tonix Pharmaceuticals (NASDAQ:TNXP) reported favorable results for the tests on its lead drug candidate TNX 102 SL. The pharma company had conducted fed-fasting and dose proportionality tests of the drug candidate in healthy volunteers. The data will be used to support a New Drug Application for treating post-traumatic stress disorderRead More →

Trading Stocks Trilogy-1: The Psychology

Gilead Against Coronavirus, And Other News: The Good, Bad And Ugly Of Biopharma – Gilead Sciences, Inc. (NASDAQ:GILD)


Gilead Tests Potential Ebola Treatment for Coronavirus Gilead Sciences (GILD) announced that it is currently in the process of evaluating the use of its experimental Ebola candidate, Nuc inhibitor GS-5734, for treating 2019-nCov infection. The company is currently engaged in active discussions with clinicians and researchers in China and theRead More →

Why geopolitical events are not a good reason to buy gold


Gold’s haven appeal amid mounting U.S.-Iran tensions and uncertainty in the Middle East could turn sour following the precious metal’s recent price rally to near seven year highs. “The geopolitical instability is adding fuel to the fire,” said Maria Smirnova, senior portfolio manager at Sprott Asset Management, following a sharpRead More →

The Jobs Report: The U.S. Is Doing Good


Well, there were 266,000 jobs added to the US job market in November and the unemployment rate hit another fifty-year low at 3.5 percent. This was better than expected. Wages were up by 3.1 percent from one year ago, while consumer prices are up by less than 2.0 percent, yearRead More →

Market Sends Good Tidings In November


Strong November returns helped solidify what has been an exceptional year for the US stock market. Retail sales rebounded, and although third-quarter earnings were not all merry and bright, most topped expectations. In the headlines, trade deal expectations continued to loom large, and while it’s certainly not a foregone conclusion,Read More →